Researchers from The Cancer Genome Atlas (TCGA) Research Network have identified novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma, the most common subtype of lung cancer. Knowledge of these genomic changes may expand the number of possible therapeutic targets for this disease and potentially identify a greater number of patients with treatable mutations because many potent cancer drugs that target these mutations already exist.
Related posts:
- Medicare Card, Study reveals genomic similarities between breast cancer and ovarian cancers Medicare Card, Study reveals genomic similarities between breast cancer and ovarian cancers...
- Medicare Card, Lung Cancer and How to Reduce Your Risk Medicare Card, Lung Cancer and How to Reduce Your Risk...
- TCGA discovers potential therapeutic targets for lung squamous cell carcinoma Researchers have identified potential therapeutic targets in lung squamous cell carcinoma, the second most common form of lung cancer. The Cancer Genome Atlas (TCGA) Research Network study that appeared online Sept. 9, 2012, and in print Sept. 27, 2012, in the journal Nature, comprehensively characterized the lung squamous cell carcinoma genome. The study found a […]...
- Medicare, Gene variations linked to lung cancer susceptibility in Asian women An international group of scientists has identified three genetic regions that predispose Asian women who have never smoked to lung cancer. The finding provides further evidence that risk of lung cancer among never-smokers, especially Asian women, may be associated with certain unique inherited genetic characteristics that distinguishes it from lung cancer in smokers....
- Medicare Card, Study shows colon and rectal tumors constitute a single type of cancer Medicare Card, Study shows colon and rectal tumors constitute a single type of cancer...
- Medicare Card, Skin Cancer and What You Need to Know Medicare Card, Skin Cancer and What You Need to Know...
- Medicare Card, Scientists Identify Markers, Human Breast Cancer Cells, Linked to Development of an Aggressive, But Less Common Form of Breast Cancer Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. In this preliminary study, estrogen-negative breast cancer developed when three markers, CD44+, CD49fhi, and CD133hi were present simultaneously on the surface of human cells taken from breast cancer patients and transplanted into a […]...
- Funded study shows 20 percent reduction in lung cancer mortality with low-dose CT compared to chest X-ray Scientists have found a 20 percent reduction in deaths from lung cancer among current or former heavy smokers who were screened with low-dose helical computed tomography (CT) versus those screened by chest X-ray. The primary research results from the National Lung Screening Trial (NLST) were published online today in the New England Journal of Medicine. […]...
- Medicare Card, Cervical Cancer Screenings Result in Early Detection Medicare Card, Cervical Cancer Screenings Result in Early Detection...
- Medicare, Lung cancer trial results show mortality benefit with low-dose CT The National Cancer Institute (NCI) is today releasing initial results from a large-scale test of screening methods to reduce deaths from lung cancer by detecting cancers at relatively early stages....
- Lung cancer trial results show mortality benefit with low-dose CT The National Cancer Institute (NCI) is today releasing initial results from a large-scale test of screening methods to reduce deaths from lung cancer by detecting cancers at relatively early stages....
- Medicare Card, Common Cancer Myths and Misconceptions Medicare Card, Common Cancer Myths and Misconceptions...
- Medicare Card, Strategy developed to improve delivery of medicines to the brain Medicare Card, Strategy developed to improve delivery of medicines to the brain...
- The Most Common Form of Brain Cancer in Adults The most common form of malignant brain cancer in adults, glioblastoma multiforme (GBM), has 4 distinct molecular subtypes, according to a new study. The finding may lead to more personalized approaches to treating GBM patients....
- Medicare Future? Pathways that Can Repair Brca1 Cancer Gene Mutation Clarified in Mice In a new study in mice, scientists have compensated for mutations in the Brca1 gene that can lead to cancer by deleting a second gene, which then lessens the probability of cancer. Mice Brca1-associated mammary tumors have significant similarities to human BRCA1- associated (BReast CAncer 1, early onset) breast cancer in regard to tumor aggressiveness, high incidence, mutations and genetic instability. The study, led by scientists at National Cancer Institute (NCI), part of the National Institutes of Health, and their colleagues, appeared online April 1, 2010 and in print April 16, 2010, in the journal Cell....